Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents
Cardiovascular disease (CVD) is the leading cause of mortality in the United States. Universal screening in all children aged 9 to 11 years and 17 to 21 years, and targeted screening in children with high-risk factors, can help in early identification and treatment of dyslipidemia during the youth, significantly reducing clinical CVD risk in adult life. Lifestyle modifications with heart-healthy diet and moderate-vigorous activ ity are fundamental in the management of pediatric dyslipidemia. Pharmacotherapy has been evolving in children, and statins, bile acid sequestrants, ezetimibe and PCSK9 inhibitors, fibrates, niacin, and omega-3 fish oils are available for use in pediatric population.
Source: Endocrinology and Metabolism Clinics of North America - Category: Endocrinology Authors: Amisha Patel, Nivedita Patni Source Type: research
More News: Bile | Cardiology | Cardiovascular | Children | Cholesterol | Diets | Endocrinology | Fish | Heart | Niacin | Niaspan | Nutrition | Omega 3 | Pediatrics | Statin Therapy | USA Health | Vitamin B3 | Vytorin | Zetia